ライフサイエンスコーパス: will be necessary to

1 is fundamental to management and conservation efforts, and will be necessary to ensure future plans and adaptation strat

2 Strong partnerships and political support and will be necessary to achieve these goals.

3 n of numerous unbiased genome-wide and proteomic approaches will be necessary to fully understand the neuroepigenome and

4 hildren in conflict-affected and security-compromised areas will be necessary to prevent reintroduction of WPV into other

5 Future refinement of biomarkers will be necessary to subclassify this group and determine the

6 Further, such comprehensive energetic characterization will be necessary to benchmark the algorithms required to rat

7 prioritisation and innovative solutions to the blood crisis will be necessary to improve this situation and will require

8 h improvements in pulse parameters and X-ray area detectors will be necessary to unlock this potential.

9 Going forward, well-defined policy direction will be necessary to institutionalize ecosystem services appr

10 dditional research into the pathophysiology of this disease will be necessary to develop newer, more targeted therapeutic

11 nough for malaria elimination but rather additional efforts will be necessary to control the disease.

12 n of, such devastating surface reactions on both electrodes will be necessary to help realize the potential of high-capac

13 Understanding of these fundamental molecular events will be necessary to identify novel host targets, such as FAK

14 Trial continuation and additional randomised evidence will be necessary to establish the supposed superior efficacy

15 Further experiments will be necessary to evaluate the efficiency and safety of th

16 Prospective clinical trials with c-Met inhibitors will be necessary to validate MET exon 14 mutations as an imp

17 It will be necessary to prioritize drugs that affect key driver

18 hophysiological processes contribute to the disease, and it will be necessary to understand this heterogeneity to find ef

19 progress from the laboratory to commercial applications, it will be necessary to develop industrially scalable methods to

20 As more RGENs become available, it will be necessary to refine their activity before they can be

21 To achieve these benefits, it will be necessary to reduce CO2 sourcing and transport burden

22 ploit the potential of CAM crops and CAM bioengineering, it will be necessary to elucidate the evolution, genomic feature

23 To fully understand behavioral evolution, it will be necessary to identify the genetic mechanisms that med

24 rove the efficacy of microelectronic retinal prosthetics it will be necessary to better understand the response of retina

25 To identify HSCs from in vitro sources, it will be necessary to refine markers of HSCs matured ex vivo.

26 Ultimately, it will be necessary to identify those patients for whom the str

27 ablers of sustainable financing, governance, and leadership will be necessary to achieve access while preventing excess a

28 ith stereopsis, visual field expansion, and quality of life will be necessary to fully evaluate the role that improved Bi

29 Further validation in cell culture and mouse models will be necessary to establish causality for these genes.

30 further development, including incorporation of ontologies, will be necessary to improve the performance of the extractio

31 ht-energy harvesting, CO2 fixation, and carbon partitioning will be necessary to make major headway toward improving phot

32 r complications although elucidation of downstream pathways will be necessary to identify targets that do not promote nep

33 y propagated species, optimization of aquaculture practices will be necessary to maximize food production and minimize ec

34 nd allow immune recognition and clearance of this reservoir will be necessary to eradicate HIV-1 in infected individuals.

35 t of hypoxia, further nutrient reductions in the Baltic Sea will be necessary to reduce the ecosystems impacts of deoxyge

36 a population isolate like Finland, and larger sample sizes will be necessary to detect risk variants.

37 ments and increased efforts from industry and civil society will be necessary to break these vicious cycles.

38 Additional studies will be necessary to characterize the predictors of cognitive

39 normalize pH and carbon dioxide levels, but further studies will be necessary to demonstrate benefit with this technology

40 Further studies will be necessary to determine which patients may benefit fro

41 Further larger studies will be necessary to determine whether specific compositional

42 Specific validation studies will be necessary to determine the best combination of imagin

43 Although a large-scale study will be necessary to confirm clinical significance, the set o

44 ral basis for how the brain tells time and operates in time will be necessary to develop general models of cognition.

45 roperties, but also their surrounding surface topographies, will be necessary to improve the yield of single quantum dot

46 Continued student tracking will be necessary to determine the long-term program effect.

47 patient population, and further adaptation of the treatment will be necessary to address the unmet needs of patients with

48 Furthermore, targeting specific cell types will be necessary to understand how regeneration of the diver

49 Longer follow up will be necessary to determine whether there is any effect on

50 Longer follow-up will be necessary to fully evaluate treatment differences.